During the past decade, Gundersen Lutheran Medical Center conducted 135 clinical trials. In the 10-year time frame, 135 clinical trials started and 133 clinical trials were completed, i.e. on average, 98.5% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 62 clinical trials were completed. i.e. 155% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gundersen Lutheran Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 140 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gundersen Lutheran Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 142 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "Radiation Therapy Oncology Group" with 7 trials as a collaborator. Other collaborators include 89 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Gundersen Lutheran Medical Center" are "Recurrent Breast Carcinoma" (11 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Breast Cancer" (8 trials) and "Fallopian Tube Transitional Cell Carcinoma" (8 trials). Many other conditions were trialed in "Gundersen Lutheran Medical Center" in a lesser frequency.

Most popular intervention types in "Gundersen Lutheran Medical Center" are "Drug" (238 trials), "Other" (172 trials), "Biological" (121 trials), "Procedure" (73 trials) and "Radiation" (62 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (93 trials), "Quality-of-Life Assessment" (71 trials), "Questionnaire Administration" (40 trials), "Paclitaxel" (39 trials) and "Biospecimen Collection" (36 trials). Other intervention names were less common.

The vast majority of trials in "Gundersen Lutheran Medical Center" are 242 trials for "All" genders, 52 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Gundersen Lutheran Medical Center". undefined are not yet recruiting, 64 are recruiting, 129 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in Gundersen Lutheran Medical Center, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Gundersen Lutheran Medical Center, 14 "Phase 1" clinical trials were conducted, 131 "Phase 2" clinical trials and 161 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".

Gundersen Lutheran Medical Center has several departments that took part in Clinical trials: "Gundersen Lutheran Center for Cancer and Blood" - 132 trials